Treatment With Intravenous Immunoglobulins and Methylprednisolone May Significantly Decrease Loss of Renal Function in Chronic-Active Antibody-Mediated Rejection
BMC Nephrology- United Kingdom
doi 10.1186/s12882-019-1385-z
Full Text
Abstract
Available in
Categories
Date
June 14, 2019
Authors
Publisher
Springer Science and Business Media LLC